Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys

Autor: Mj, Kuroda, Joern E Schmitz, Seth A, Rs, Veazey, Ce, Nickerson, Ma, Lifton, Pj, Dailey, Ma, Forman, Racz P, Tenner-Racz K, Nl, Letvin

Publikováno v: Europe PubMed Central

Major histocompatibility class I-peptide tetramer technology and simian immunodeficiency virus of macaques (SIVmac)-infected rhesus monkeys were used to clarify the distribution of acquired immunodeficiency syndrome virus-specific cytotoxic T lymphoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::668457d1a2698654e4e730c155bad843
https://pubmed.ncbi.nlm.nih.gov/10942394

SARS-CoV-2 infection protects against rechallenge in rhesus macaques.

Autor: Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Martinot AJ; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Tufts University Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA., McMahan K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Mercado NB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Tostanoski LH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Yu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Maliga Z; Harvard Medical School, Boston, MA 02115, USA., Nekorchuk M; Oregon Health & Sciences University, Beaverton, OR 97006, USA., Busman-Sahay K; Oregon Health & Sciences University, Beaverton, OR 97006, USA., Terry M; Oregon Health & Sciences University, Beaverton, OR 97006, USA., Wrijil LM; Tufts University Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA., Ducat S; Tufts University Cummings School of Veterinary Medicine, North Grafton, MA 01536, USA., Martinez DR; University of North Carolina, Chapel Hill, NC 27599, USA., Atyeo C; Harvard Medical School, Boston, MA 02115, USA.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Fischinger S; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Burke JS; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Slein MD; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA., Pessaint L; Bioqual, Rockville, MD 20852, USA., Van Ry A; Bioqual, Rockville, MD 20852, USA., Greenhouse J; Bioqual, Rockville, MD 20852, USA., Taylor T; Bioqual, Rockville, MD 20852, USA., Blade K; Bioqual, Rockville, MD 20852, USA., Cook A; Bioqual, Rockville, MD 20852, USA., Finneyfrock B; Bioqual, Rockville, MD 20852, USA., Brown R; Bioqual, Rockville, MD 20852, USA., Teow E; Bioqual, Rockville, MD 20852, USA., Velasco J; Bioqual, Rockville, MD 20852, USA., Zahn R; Janssen Vaccines & Prevention BV, Leiden, Netherlands., Wegmann F; Janssen Vaccines & Prevention BV, Leiden, Netherlands., Abbink P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Bondzie EA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Dagotto G; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Gebre MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., He X; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Jacob-Dolan C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.; Harvard Medical School, Boston, MA 02115, USA., Kordana N; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Li Z; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Lifton MA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Mahrokhian SH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Maxfield LF; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Nityanandam R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Nkolola JP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA., Schmidt AG; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02215, USA., Miller AD; Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA., Baric RS; University of North Carolina, Chapel Hill, NC 27599, USA., Alter G; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02215, USA., Sorger PK; Harvard Medical School, Boston, MA 02115, USA., Estes JD; Oregon Health & Sciences University, Beaverton, OR 97006, USA., Andersen H; Bioqual, Rockville, MD 20852, USA., Lewis MG; Bioqual, Rockville, MD 20852, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. dbarouch@bidmc.harvard.edu.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.; Massachusetts Consortium on Pathogen Readiness, Boston, MA 02215, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2020 Aug 14; Vol. 369 (6505), pp. 812-817. Date of Electronic Publication: 2020 May 20.

Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques.

Autor: Sixsmith JD; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Panas MW; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Lee S; Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Gillard GO; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., White K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Lifton MA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Balachandran H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Mach L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Miller JP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Lavine C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., DeMarco CT; Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Tomaras GD; Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Gee C; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Porcelli SA; Howard Hughes Medical Institute, Department of Microbiology & Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA., Larsen MH; Howard Hughes Medical Institute, Department of Microbiology & Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA., Frothingham R; Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Schmitz JE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Jacobs WR Jr; Howard Hughes Medical Institute, Department of Microbiology & Immunology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York, USA., Haynes BF; Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Letvin NL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Korioth-Schmitz B; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA bkorioth@bidmc.harvard.edu.

Publikováno v: Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2014 Oct; Vol. 21 (10), pp. 1385-95. Date of Electronic Publication: 2014 Jul 30.

Vaccination reduces simian-human immunodeficiency virus sequence reversion through enhanced viral control.

Autor: Manuel ER; Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA., Yeh WW, Balachandran H, Clarke RH, Lifton MA, Letvin NL

Publikováno v: Journal of virology [J Virol] 2010 Dec; Vol. 84 (24), pp. 12782-9. Date of Electronic Publication: 2010 Sep 29.

Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans.

Autor: O'Brien KL; Division of Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Liu J, King SL, Sun YH, Schmitz JE, Lifton MA, Hutnick NA, Betts MR, Dubey SA, Goudsmit J, Shiver JW, Robertson MN, Casimiro DR, Barouch DH

Publikováno v: Nature medicine [Nat Med] 2009 Aug; Vol. 15 (8), pp. 873-5. Date of Electronic Publication: 2009 Jul 20.